A Therapeutic Approach From Lab to Clinic in the Domain of the Disease Caused by the Novel Coronavirus From the Perspective of an Egyptian Scientist

Laila Mahmoud Montaser

Department of Clinical Pathology, Egypt

Dr. Laila Mahmoud Montaser, Department of Clinical Pathology, Egypt.

Keywords: Coronavirus; COVID-19; Pneumonia; Convalescent Plasma; Platelet-Rich Plasma Rich in Growth Factors

Abstract

There was a problem started by Pneumonia of unknown cause detected in Wuhan, China. Every morning we wake up to the news about the contemporary pandemic in serious pneumonia caused by coronavirus. The coronavirus now is pandemic killed and infected thousands people according to World Health Organization (WHO). The coronavirus is a newly identified pathogen and there is no known pre-existing immunity in humans. Infection rates and death toll are rising. This crisis affects our attitude and our practice, as it certainly affects our lives. WHO characterizes COVID-19 as pandemic and so calls for urgent, aggressive actions to combat the virus [1]. Presently there are no vaccines or drugs available for COVID-19. Therefore, proposal of a therapy with accessible, rationale and applicable technique is urgently needed.

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).